Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Pharmalot
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Adam's Take
STAT+

Maraganore victorious in best biopharma CEO tally; Vounatsos tops worst list

  • Adam Feuerstein

By Adam Feuerstein Dec. 20, 2019

Reprints
Good/Bad CEO 2017
Hyacinth Empinado/STAT

Polls are closed and the votes have been counted. STAT readers have crowned the best and worst biopharma CEOs of 2019 — and it’s an all-Cambridge, Mass., pairing.

The best: John Maraganore of Alnylam Pharmaceuticals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Tags

Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Why you get paid to donate plasma but not…
Why you get paid to donate plasma but not blood
The surprising biomedical legacy of the Iraq War
The surprising biomedical legacy of the Iraq War
Listen: Bancel v. Bernie, Sarepta’s FDA runaround, & Regeneron’s…
Listen: Bancel v. Bernie, Sarepta’s FDA runaround, & Regeneron’s ever-growing blockbuster
FDA advisory panel recommends conditional approval of Biogen’s drug…
FDA advisory panel recommends conditional approval of Biogen’s drug for rare form of ALS

Recommended Stories